Southeast Asia’s healthcare is at a turning point

      With an aging population, rising medical inflation (projected at 15 percent in 2025, well above the global average), and over 80 percent of people unable to afford advanced care, the region faces urgent challenges. By 2050, 16 percent of Southeast Asians will be over 65, led by Thailand (30 percent) and Singapore (27 percent) — making innovation in healthcare more critical than ever.

      MedTech is the lifeline

      From AI that can slash hospital wait times by 122 hours and save thousands of dollars daily, to portable diagnostics and genomic testing, MedTech solutions are poised to transform care delivery. The sector is set to grow at a 7.6 percent CAGR between 2025 and 2030.

      KPMG Asia Pacific’s three-part Innovate to Integrate series explores the “3As” which are essential for scaling MedTech across the region.

      • Achieving acceptance
      • Articulating value
      • Accessibility in affordability

      #

      Start with the executive summary. Get the insights. Be ready for what’s next.

      This executive summary is just the start. The next three parts in the series will dive deeper into adoption strategies, regional case studies, and recommendations for MedTech companies, policymakers, and healthcare providers. The first in the series will be released in October 2025.


      Related content

      Key considerations to help improve trust, access and adoption of AI in MedTech

      Perspectives on emerging challenges and opportunities for improving mental health outcomes in the Asia Pacific region.

      Our people

      Peter Liddell

      Global Sustainable Supply Chain Lead and Partner

      KPMG in Singapore

      Anastasia Miros

      Director, Healthcare and Life Sciences, Asia Pacific

      KPMG in Singapore